Bofukang vaginal suppository for aerobic vaginitis symptoms
Part of Women’s health & pregnancy clinical trials.
This trial studies whether Bofukang vaginal suppositories can improve symptoms and abnormal vaginal test results in people with aerobic vaginitis. If you meet the specific diagnosis and safety criteria, it may offer a structured treatment plan and follow-up to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with aerobic vaginitis based on your vaginal discharge, vaginal pH over 4.5, and a Donders score of 3 or higher
- You have no signs of other vaginal infections (like gonorrhea or herpes) and no cervical/vulvar conditions such as cervical erosion or other vulvar diseases
- You have not used antibiotic or antifungal medicines by mouth or in the vagina within the past 2 weeks
- You are not pregnant, breastfeeding, or planning pregnancy during the study
- You do not have serious medical problems like significant liver/kidney problems, weak immunity, diabetes, or serious mental illness (psychosis)
- You are not allergic to Bofukang or its ingredients, and you can reliably follow study visits and instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This study tests a vaginal ovule (a small tablet inserted into the vagina) to see if it safely treats two common vaginal infections: bacterial vaginosis and yeast infections (candidiasis). It may help relieve symptoms like discharge, itching, and burning.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
This study tests two new investigational drugs to treat bacterial vaginosis. It aims to see if these drugs are safe and work well. If you have BV, this trial could give you access to a new treatment option.
This study tests whether a vaginal probiotic called Gyntima Balance can help prevent bacterial vaginosis from coming back. If you have had repeat infections, this might be a way to reduce future episodes.
Hear when a new Vaginitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.